J&J Wins Rapid Approval Of Specialized TB Drug
The U.S. Food and Drug Administration on Monday announced it has granted early approval to Johnson & Johnson's Sirturo as the first medication for a rare and stubborn form of tuberculosis,...To view the full article, register now.
Already a subscriber? Click here to view full article